References
- Picchionl A. L., Chin L., Gillespie T. Evaluation of activated charcoal-sorbitol suspension as an antidote. J. Toxicol.: Clin. Toxicol. 1982; 19: 433–444
- Curtis R. A., Barone J., Giacona N. “Efficacy of ipecac and activated charcoal/cathartic”, prevention of salicylate absorption in a simulated overdose. Arch. Intern. Med. 1984; 144: 48–52
- Brown J. L. Incomplete labeling of pharmaceuticals: A list of “inactive ingredients”. N. Engl. J. Med. 1983; 309: 439–141
- Wick A. N., Almen M. C., Joseph L. The metabolism of sorbitol. J. Am. Pharm. Assoc. 1951; 40: 542–544
- Brunzell J. D. Use of fructose, xylitol, or sorbitol as a sweetener in diabetes mellitus. Diabetes Care 1978; 1: 223–230
- Hyams J. S. Chronic abdominal pain caused by sorbitol malabsorption. J Pediatr 1982; 100: 772–773
- Anderson C. C., Shahvari M. B.G., Zimmerman J. E. The treatment of pulmonary edema in the absence of renal function, a role for sorbitol and furosemide. JAMA 1979; 241: 1008–1010
- Schulte M. J., Lenz W. Fatal sorbitol infusion in patient with fructose-sorbitol intolerance. Lancet. 1977; 2: 188
- Dorwart W. V., Chalmers L. Comparison of methods for calculating serum osmolality from chemical concentrations and the prognostic value of such calculations. Clin Chem. 1975; 21: 190–194
- Chin L. Induced Emesis, A questionable procedure for the treatment of acute poisoning. Am J HOSD Pharm 1972; 29: 877–879
- Spyker D. A. Activated charcoal reborn: progress in poison management. Archives of Int Med, in press
- Krenzelok E. P. Comparison of cathartics used With activated charcoal. Vet. Hum. Toxicol. 1984; 26, Abstract 402
- Buchsbaum M., Harris E. K. Diurnal variation in serum and urine electrolytes. J. ADD. Physiol. 1971; 30: 27–35
- Wills M. R. The clinical effect of diurnal variation on the total plasma calcium concentration in normal subjects. J. Clin. Path 1970; 23: 772–777